Hypertension Not Adequately Controlled
Mohamed A. El-Shahawy, MD, MPH, MHA, FASN, CPI
Director and Principal Investigator
Clinical Professor of Medicine (Adjunct), Keck School of Medicine of USC
Protocol Overview
This clinical trial aim at evaluating the efficacy of New Medication at achieving better control of Blood Pressure, in addition to evidence-based standard of care aiming at prevention of cardiovascular events.
Key Inclusion Criteria
- Male or Female age 40 years or older.
- History or high risk of Cardiovascular disease. (e.g., Heart Attack Hypertension, Stroke, Heart Failure).
- Treated hypertension on stable therapy with 2 to 4 antihypertensive medications.
- Seated automated mean office Systolic Blood Pressure ≥140 mmHg
Why Join This Clinical Trial?
– Access to highly experienced Board certified Nephrologists
– Participation is voluntary, and you will learn all details about the protocol by Contacting with our clinical team contact us.
– Clinical trials offer additional care options for your condition, with access to new medicines at no cost.
– Help move science forward and improve human health, wellbeing, and quality of life.
– No cost to participate.
Connect with Our Clinical Team
